GILD vs ZYDUSLIFE.NS — which is stronger right now?
Same dated snapshot (2026-09-01): GILD quality 100/100 vs ZYDUSLIFE.NS —/100; engine LONG vs LONG. The comparison below is computed, dated, and auditable — not an opinion.
| Snapshot | 2026-09-01 · source: yahoo | |
|---|---|---|
| GILD (Gilead) | ZYDUSLIFE.NS (Zydus Lifesciences) | |
| Market / sector | us · Healthcare | in · Pharma |
| Price | $148.86 | ₹1,173 |
| Quality score | 100/100 | —/100 |
| Engine signal | LONG · 313 bars · uPnL +34.0% | LONG · 96 bars · uPnL +25.3% |
| Total return | +34.0% | +15.8% |
Thesis-break template (Healthcare)
flagship drug losing exclusivity; pivotal trial failure; pricing-policy shifts; payer consolidation
Cite this page
Balance Labs Research Desk (2026-09-01). "GILD vs ZYDUSLIFE.NS — which is stronger right now?." balancelabs.app · https://balancelabs.app/stocks/compare/gild-vs-zyduslife.ns · CC BY 4.0
Ask anything
30 free credits monthly · no card required · research support, not advice
← compare hub · snapshot 2026-09-01 · not investment advice